Discover how advanced Battery Management Systems (BMS) are enhancing electric vehicle efficiency and reliability by embedding ...

This partnership with Delta not only integrates our batteries with Delta's core power management capabilities to provide customers with a safer, high-efficiency, and energy-saving next-generation ...

Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Battery Management ...

Cash management is critical for pharmaceutical companies: The ability to fund drug innovation can make the difference between ...

The atherosclerotic cardiovascular disease market in the 7MM is expected to show positive growth during the forecast period (2025–2034), mainly attributed to the launch of upcoming therapies such as ...

Ferrari's new active suspension system drives the wheels up and down with 48-volt motors linked to each damper, eliminating ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Bristol Myers Squibb (BMS) has secured another win for Opdivo (nivolumab), becoming the only FDA-approved PD-1 inhibitor for resectable non-small cell lung cancer NSCLC in both a neoadjuvant-only ...

The production of clean hydrogen through water electrolysis is a promising route toward emission-free and sustainable energy ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) ...